Alpha DNA Investment Management’s Globant GLOB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,218
Closed -$1.64M 133
2021
Q4
$1.64M Buy
+5,218
New +$1.54M 1.03% 32
2021
Q2
Sell
-2,881
Closed -$597K 315
2021
Q1
$597K Buy
2,881
+2,860
+13,619% +$607K 0.69% 79
2020
Q4
$4K Buy
+21
New +$4.06K ﹤0.01% 395

Other funds holding GLOB

Alpha DNA Investment Management's GLOB Position: Q1 2022 in Review

Alpha DNA Investment Management sold out of Globant (GLOB) in Q1 2022, closing a stake of 5,218 shares — an estimated $1.64M sold.

Alpha DNA Investment Management first reported a position in GLOB in Q4 2020 and held it in 3 quarters. The position peaked at $1.64M in Q4 2021. 357 funds tracked by Wall St. Rank hold GLOB as of Q1 2022.

  • Alpha DNA Investment Management reported no remaining Globant position as of Q1 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 5,218 Globant shares in Q1 2022, an estimated $1.64M.
  • Alpha DNA Investment Management first reported a position in Globant in Q4 2020 and held it in 3 quarters.
  • Alpha DNA Investment Management's Globant position peaked at $1.64M in Q4 2021.
  • 357 funds tracked by Wall St. Rank held Globant as of Q1 2022.

Based on Alpha DNA Investment Management's 13F filing for Q1 2022, filed 13 May 2022.